Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter randomized double-blind placebo-controlled phase II study of TVAX-008 injection in treated chronic hepatitis B patients
CTR20231429Phase 2Active
- Sponsor
- Sciwind Biosciences
- Start
- Jun 2023
- Modality
- Cancer Vaccines → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of TVAX-008 in Chronic Hepatitis B (CHB), sponsored by Sciwind Biosciences. Started Jun 2023; status: active.
02
Drugs
TVAX-008
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on CTR20231429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231429.